EUTM file information

001832765

HUMAX


August 30, 2000

Trademark Summary

The trademark HUMAX was filed by Genmab A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on May 20, 2001, and received one opposition filed on August 13, 2001 by LABORATOIRES D'HYGIENE ET DE DIETETIQUE (L.H.D.) (SOCIETE ANONYME) on Likelihood of confusion. the opponent was represented by CABINET BEAU DE LOMENIE and proceedings were handled in French, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 13, 2001

The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).

Two renewals of the trademark were recorded, one on June 22, 2010, and the other one on March 12, 2020.

Appointment and Replacement of representative of the trademark registration was recorded on August 26, 2001. Change of name and address of the trademark registration was recorded on March 24, 2006. Change of name and address of the trademark registration was recorded on July 15, 2007. Partial Surrender of the trademark registration was recorded on June 22, 2010. Change of name and address of the trademark registration was recorded on November 29, 2010. Appointment and Replacement of representative of the trademark registration was recorded on February 9, 2011. Change of name and address of the trademark registration was recorded on November 20, 2012. Change of name and professional address of the trademark registration was recorded on October 10, 2016. Change of name and professional address of the trademark registration was recorded on March 28, 2017. Change of name and address of the trademark registration was recorded on August 15, 2017.


Goods And Services

  • The mark was filed in class 1 with Chemicals used in industry, science and photography, including biochemicals, especially, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases and none of these chemicals for use in scientific research and development in connection with respiratory infectious affections..
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical, veterinary and sanitary preparations, including pharmaceutical preparations based on human monoclonal antibodies
    2. Dietetic substances adapted for medical use, food for babies
    3. Plasters, materials for dressings
    4. Material for stopping teeth, dental wax
    5. Disinfectants
    6. None of the before mentioned preparations for the treatment of respiratory infectious affections.